The Cardiovascular Disease Prevention Learning Pathway at ACC.25 will showcase the rapid evolution of preventive cardiology, from breakthrough therapeutics to innovative prevention strategies. During this unforgettable experience, taking place March 29-31 in Chicago, IL, experts will help you master both foundational approaches and cutting-edge developments that are transforming cardiovascular risk reduction. Attend sessions on SGLT2 inhibitors, GLP-1RA, and the intricate relationships between cardiac, kidney, and metabolic disease. Plus, catch a year in review by Erica Sarah Spatz, MD, FACC. Register here.